Johannes Christian Hellmuth
Overview
Explore the profile of Johannes Christian Hellmuth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hofmann A, Vehreschild J, Witzenrath M, Hoffmann W, Illig T, Schreiber S, et al.
Gesundheitswesen
. 2024 Aug;
86(10):647-654.
PMID: 39173676
In the early phase of the COVID-19 pandemic, many local collections of clinical data on patients infected with SARS-CoV-2 were initiated in Germany. As part of the National Pandemic Cohort...
2.
Steinbeis F, Thibeault C, Steinbrecher S, Ahlgrimm Y, An Haack I, August D, et al.
Infection
. 2023 Jul;
52(1):93-104.
PMID: 37434025
Background: The severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic causes a high burden of acute and long-term morbidity and mortality worldwide despite global efforts in containment, prophylaxis, and...
3.
Vielhauer J, Benesch C, Pernpruner A, Johlke A, Hellmuth J, Muenchhoff M, et al.
Thromb J
. 2023 May;
21(1):51.
PMID: 37131204
Background: Pulmonary embolism (PE) is an important complication of Coronavirus disease 2019 (COVID-19). COVID-19 is associated with respiratory impairment and a pro-coagulative state, rendering PE more likely and difficult to...
4.
Roessler J, Pich D, Albanese M, Wratil P, Krahling V, Hellmuth J, et al.
PNAS Nexus
. 2022 Nov;
1(2).
PMID: 36382127
Neutralizing antibodies (NAbs), and their concentration in sera of convalescents and vaccinees are a correlate of protection from COVID-19. The antibody concentrations in clinical samples that neutralize SARS-CoV-2 are difficult...
5.
Khatamzas E, Antwerpen M, Rehn A, Graf A, Hellmuth J, Hollaus A, et al.
Nat Commun
. 2022 Sep;
13(1):5586.
PMID: 36151076
Antibodies against the spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can drive adaptive evolution in immunocompromised patients with chronic infection. Here we longitudinally analyze SARS-CoV-2 sequences in a...